July 29, 2014 12:51 AM ET


Company Overview of PharmaLundensis AB

Company Overview

PharmaLundensis AB operates as a pharmaceutical company in Sweden. It is conducting clinical research, which has completed Phase I and Phase IIa clinical stages for developing drug for the treatment of chronic obstructive pulmonary disease. The company was founded in 2006 and is based in Lund, Sweden.

Scheelevägen 2

Medicon Village

Lund,  223 81


Founded in 2006


46 46 13 27 80


46 46 13 27 79

Key Executives for PharmaLundensis AB

PharmaLundensis AB does not have any Key Executives recorded.

PharmaLundensis AB Key Developments

PharmaLundensis AB to Report Q1, 2014 Results on May 15, 2014

PharmaLundensis AB announced that they will report Q1, 2014 results on May 15, 2014

PharmaLundensis AB to Report Fiscal Year 2013 Results on Feb 20, 2014

PharmaLundensis AB announced that they will report fiscal year 2013 results on Feb 20, 2014

PharmaLundensis AB to Report Q3, 2013 Results on Nov 21, 2013

PharmaLundensis AB announced that they will report Q3, 2013 results on Nov 21, 2013

Similar Private Companies By Industry

Company Name Region
Novozymes Biopharma SE AB Europe
BioLamina AB Europe
Premune AB Europe
Probi Feed AB Europe
Archaea Pharma AB Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PharmaLundensis AB, please visit www.pharmalundensis.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.